As the developer of Programming at the International Economic Development Council (IEDC), Claudia Bellony-Atanga creates and builds the robust content for IEDC’s conferences. She also leads IEDC’s Higher Education Advisory Committee as their staff liaison. Claudia is an advocate for economic equity, women empowerment and equality, entrepreneurship, with data-driven results. She uses creative endeavors to maximize and improve the work in community and economic development.
Archives: Speakers
Fatima Hadj
Karin Barthelmes-Wehr
Karin Barthelmes-Wehr is Managing Director of the Institute for Corporate Governance in the German Real Estate Industry (ICG) – the leading Think and Do Tank for all topics related to sustainable leadership. She has been involved in building up the institute since 2003.
Karin is also Chair of the International Ethics Standards Coalition which was initiated by the United Nations in 2014. The coalition’s aim is to establish and implement a common code of ethics in the real estate industry worldwide. To date, around 150 real estate bodies from almost 50 countries (as well as just as many companies, universities and government organisations) have joined the coalition.
Apart from other honorary appointments, Karin is member of the advisory committee of the Real Estate Department of HAWK (Hildesheim/Holzminden University of Applied Sciences), a juror for the polis AWARD and founding member and mentor at the cross industry program Initiative Women into Leadership (IWiL). She holds a Master’s degree (suma cum laude) in English, Romance Philology and Political Science from the University of Münster and has more than 25 years of experience in the real estate industry. Before joining ICG, Karin worked in real estate conference management for EUROFORUM/”Handelsblatt” and in executive search at Heidrick & Struggles. In 2020, the jury of “Immobilien Manager” selected her as the top 1 “Real Estate Influencer”, the category of “Real Estate Women with a Strong Presence and High Reputation”.
Agnes Jung
SeungAh Choe
Ki Hwan Kim
Nari Yun
Dr. Yun began her career at Hanmi Pharmaceuticals, took the major role in managing all activities associated with the clinical development programs for key assets including long-acting insulin, GLP-1 agonist and GLP-1/GCG dual agonist. She engaged in full courses of drug development, ranging from CDP/TPP development, clinical strategy formulation and operations, licensing out and co-development with partners. She also served as a strategic consultant in IQVIA, worked on consulting projects for key business decisions, including business planning and strategy formulation, asset valuation and pricing & reimbursement strategy for various drugs etc.
In September 2019, Dr. Yun joined to GI Innovation and has led clinical collaboration agreement of company’s immunooncology asset with global pharmaceutical companies, including MSD and AstraZeneca. She is now serving as a head of clinical development.
Dr. Yun is a registered pharmacist in Korea and was educated at School of Pharmacy, Sunkyunkwan University, where she received her PhD in pharmacology in 2012.
Chunwon
Bibi Sattar Marques
Bibi is specialized in the financial sector with over 18 years of professional experience, as a result of her passages at PwC and ANACOM, acquiring solid knowledge in financial auditing, corporate finance, and regulation, having been a member of the Regulatory Accounting Group – Board of European Regulators of Electronic Communications.
In 2017, Bibi accepted the challenge to develop the Venture Capital arm in a financial entity as partner and member of the Board of Directors. In 4 years, the first nine venture capital funds were created with more than €100m+ under management, becoming the reference area of this financial entity.
In the context of corporate social responsibility, in 2019, she joined GRACE’s Advisory Board.
In 2021, Bibi, challenged by the GED group, joins the company as Partner and member of the Board of Directors of GED Ventures Portugal to develop the Venture Capital arm and strengthen the company’s Iberian leadership.
Gareth Presch
Gareth is a global healthcare thought leader and the Founder and CEO of the World Health Innovation Summit. He is the Expert Lead on SDG3/4 for the UNGSII Foundation 25+5 SDG Cities Leadership Platform, Founder of the Global Social Prescribing Alliance, and a Member of Pope Francis’s Vatican COVID19 Commission Group 2 Looking to the Future.